These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 9636471)
1. Immunoglobulin class switch of posttransplant panel reactive antibody and the impact on kidney allograft outcome. Sumethkul V; Mongkolsuk T; Sujirachato K; Chiewsilp P Transplant Proc; 1998 Jun; 30(4):1167. PubMed ID: 9636471 [No Abstract] [Full Text] [Related]
2. Pretransplant and posttransplant monitoring of anti-HLA class I IgG1 antibodies by ELISA identifies patients at high risk of graft loss. Monteiro F; Mineiro C; Rodrigues H; de Paula FJ; Kalil J Transplant Proc; 1997; 29(1-2):1433-4. PubMed ID: 9123368 [No Abstract] [Full Text] [Related]
4. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
5. Effect of HLA semi-identical pretransplant blood transfusions on renal allograft outcome. Mariat C; Alamartine E; De Filippis JP; Deprele C; Le Petit JC; Goure D; Berthoux F Transplant Proc; 2000 Mar; 32(2):381-3. PubMed ID: 10715446 [No Abstract] [Full Text] [Related]
6. Significance of antidonor blood type antibody for long-term graft acceptance in ABO-incompatible kidney transplantation. Hadano T; Ohara T; Aikawa A; Hasegawa A Transplant Proc; 2000 Nov; 32(7):1847-9. PubMed ID: 11119966 [No Abstract] [Full Text] [Related]
9. The development of chronic renal allograft rejection may be predicted early following transplantation. O'Malley KJ; Cook DJ; Flechner SM; McCarthy JF; Thorne NA; Boparai N; Mastroianni BA; Papajcik DA; Modlin CS; Goldfarb DA; Novick AG Transplant Proc; 1999; 31(1-2):1352-3. PubMed ID: 10083599 [No Abstract] [Full Text] [Related]
10. Clinical and immunologic characteristics of transplant recipients with recurrent acute rejection episodes. Jacobs U; Niese D; Brensing KA; Klein B; Buszello H; Klehr HU Transplant Proc; 1996 Dec; 28(6):3231-3. PubMed ID: 8962250 [No Abstract] [Full Text] [Related]
11. Evolution of chronic antibody mediated-rejection: a case report. Cornell LD; Wong W; Saidman S; Collins AB; Colvin RB Clin Transpl; 2006; ():463-7. PubMed ID: 18365404 [No Abstract] [Full Text] [Related]
12. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss. Lee PC; Zhu L; Terasaki PI; Everly MJ Transplantation; 2009 Aug; 88(4):568-74. PubMed ID: 19696641 [TBL] [Abstract][Full Text] [Related]
13. HLA class I residue mismatch and renal graft outcome. Piazza A; Canossi A; Buonomo O; Di Rocco M; Del Beato T; Torlone N; Felici A; Cortini C; Casciani CU; Adorno D Transpl Int; 2000; 13 Suppl 1():S444-8. PubMed ID: 11112050 [TBL] [Abstract][Full Text] [Related]
14. Living related donor kidney transplantation in patients with a positive flow cytometry crossmatch. Hong JH; Sadeghian M; Sumrani N; Distant DA; Sommer BG; Norin AJ Transplant Proc; 1996 Jun; 28(3):1614-5. PubMed ID: 8658808 [No Abstract] [Full Text] [Related]